Pfizer picture

Pfizer awaits verdict on contaminated site clean-up plan

December 13, 2011
Manufacturing and Production, Sales and Marketing FDA, Pfizer, manufacturing

The US Environmental Protection Agency is due to deliver a verdict on a $205 million proposal by Pfizer to clean …

Katherine Baicker elected to Lilly’s board of directors

December 12, 2011
Business Services, Research and Development, Sales and Marketing lilly

Lilly has elected Katherine Baicker as a new member of its board of directors, effective immediately. Baicker, 40, is Professor …

New report highlights postcode lottery for medicines

December 12, 2011
DoH, NHS, UK

A new report by the Department of Health illustrates a stark postcode lottery in drug spend for patients with chronic …

Tyverb picture

GSK’s Tyverb fails late-stage trial in breast cancer

December 12, 2011
Research and Development, Sales and Marketing GSK, Tyverb, breast cancer

GlaxoSmithKline’s Tyverb has failed to help women with HER2 positive breast cancer increase their survival.  The TEACH study’s primary objective …

Jim Easton picture

Who’s really in charge of the new NHS?

December 12, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NHS reform

Each year the health service, the Department of Health and the UK pharmaceutical industry get an opportunity to say what …

EMA picture

EMA and FDA move closer on inspections

December 12, 2011
Manufacturing and Production EMA, FDA

The EMA and US FDA has taken a step closer to mutual recognition of manufacturing site inspections, launching a three-year …

Janssen inks $150m deal for blood cancer drug

December 12, 2011
Research and Development, Sales and Marketing Janssen, Pharmacyclics

Janssen biotech has signed a licensing deal with Pharmacyclics for its investigational blood cancer drug. The firm has paid $150 …

SHL receives great response at the 2011 PDA in Basel

December 12, 2011
Manufacturing and Production autoinjector, pda, pen injector, prefilled syringe, shl group

SHL successfully wrapped up this year’s exhibition at the PDA’s ” The Universe of Pre-filled Syringes and Injection Devices” 2011 …

Takeda’s blood pressure treatment Edarbi approved

December 9, 2011
Sales and Marketing Diovan, Eisai, cardiovascular, high blood pressure, hypertension

Takeda’s new hypertension treatment Edarbi has been approved in Europe.Edarbi (azilsartan medoxomil) is a new once-daily angiotensin receptor blocker (ARB) …

Succinct Communications makes three appointments

December 9, 2011
Business Services, Medical Communications, Sales and Marketing Succinct

Succinct Communications has appointment a number of new staff members to support the growth of its organisation. Chris Stevenson joins …

Dechra Pharmaceuticals PLC FDA Approval for manufacturing at Dales Pharmaceuticals

December 9, 2011
Manufacturing and Production, Research and Development FDA Approval

Dechra® Pharmaceuticals PLCFDA APPROVAL FOR MANUFACTURING AT DALES® PHARMACEUTICALS  Dales Pharmaceuticals (‘Dales’ or the ‘Company’), based in Skipton, North Yorkshire, UK, …

Erectile dysfunction drugs restricted on NHS

December 9, 2011
Sales and Marketing Cialis, ED, Levitra, NHS, PCTs, viagra

Health authorities in England are restricting the use of erectile dysfunction drugs to help cut costs. Pfizer’s Viagra, Lilly’s Cialis …

Novartis' facility in North Carolina

Novartis warned over standards at generics sites

December 9, 2011
Manufacturing and Production CGMP Failures, FDA compliance, Novartis, Sandoz

The FDA has warned Novartis that three North American production facilities operated by its generics subsidiary Sandoz are failing to …

Dr Rajeev Venkayya to head Takeda’s new vaccine business

December 9, 2011
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Takeda

Takeda will establish a new vaccine business division in January next year and will appoint Dr Rajeev Venkayya as its …

Roche picture

Roche’s new breast cancer drug succeeds in late-stage trial

December 9, 2011
Research and Development, Sales and Marketing Roche, breast cancer, pertuzumab

Roche’s next generation breast cancer drug pertuzumab has helped patients to live over six months longer. CLEOPATRA, the first randomised …

daxas_web

NICE rejects Merck’s COPD drug Daxas

December 9, 2011
Sales and Marketing COPD, Daxas, Merck, Nycomed

NICE has not recommended Merck’s COPD drug Daxas and is asking for a new clinical trial to test its effectiveness. …

Mike Farrar

NHS to collaborate with pharma on innovation

December 8, 2011
Sales and Marketing ABPI, NHS, NHS Confederation, collaboration

 The NHS Confederation is to hold a series of strategic meetings with the pharma industry and the medical technology industries …

facebookweb

Europeans keen on medicines info – but not via Facebook or Twitter

December 8, 2011
Medical Communications Digital Blog, Facebook

 A new survey finds demand for information on medicines is strong in Europe, but consumers aren’t using social sites such …

AstraZeneca's global headquarters in London

AstraZeneca to cut 1,150 staff in the US

December 8, 2011
Research and Development, Sales and Marketing AstraZeneca, cuts

AstraZeneca will cut around 1,150 positions in the US as large patent expiries loom. The cuts will come primarily from …

Deepak Khanna becomes new ABPI president-elect

December 8, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Deepak Khanna

Deepak Khanna, senior vice president and UK managing director of Merck, Sharp and Dohme has been named as president-elect of …

The Gateway to Local Adoption Series

Latest content